PO-REN HSUEHHsiao C.-H.SHIOU-HWEI YEHWang W.-K.PEI-JER CHENJIN-TOWN WANGSHAN-CHWEN CHANGCHUAN-LIANG KAOPAN-CHYR YANGDING-SHINN CHENLee Y.-T.Teng C.-M.HONG-NERNG HOMING-FU CHANG2019-11-112019-11-112003https://www.scopus.com/inward/record.uri?eid=2-s2.0-84983719141&doi=10.3201%2feid0909.030367&partnerID=40&md5=faa7f1a4a695b353807878b8abd43b7dhttps://scholars.lib.ntu.edu.tw/handle/123456789/431073The genome of one Taiwanese severe acute respiratory syndrome-associated coronavirus (SARS-CoV) strain (TW1) was 29,729 nt in length. Viral RNA may persist for some time in patients who seroconvert, and some patients may lack an antibody response (immunoglobulin G) to SARS-CoV >21 days after illness onset. An upsurge of antibody response was associated with the aggravation of respiratory failure.[SDGs]SDG3corticosteroid; immunoglobulin; immunoglobulin G; methylprednisolone; nucleic acid; ribavirin; virus RNA; adult; adult respiratory distress syndrome; antibiotic therapy; antibody response; antibody titer; article; artificial ventilation; clinical article; complement fixation test; Coronavirus; cytopathogenic effect; diarrhea; enzyme linked immunosorbent assay; erythrophagocytosis; female; fever; human; malaise; male; myalgia; nucleotide sequence; pancytopenia; respiratory failure; reverse transcription polymerase chain reaction; rigor; SARS coronavirus; seroconversion; severe acute respiratory syndrome; syndrome delineation; Taiwan; Vero cell; virus genome; virus pneumonia; virus strainMicrobiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwanjournal article10.3201/eid0909.0303672-s2.0-84983719141